Additionally, analysis of data from The Cancer Genome Atlas (TCGA) CRC patients suggested that higher MGP expression was correlated with worse overall survival (χ2 = 8.7, p = 0.0032, Figure 1G) and disease-free survival (χ2 = 6.6, p = 0.0103, Figure 1H). The gene discussed is MGP; the disease is colorectal carcinoma.